Immunohistochemical and Morphometric Analysis of Lung Tissue in Fatal COVID-19
Authors:
- Ioana-Andreea Gheban-RoșcaIGIoana-Andreea Gheban-Roșca
- Bogdan-Alexandru GhebanBGBogdan-Alexandru Gheban
- Bogdan PopBPBogdan Pop
- Daniela-Cristina MironescuDMDaniela-Cristina Mironescu
- Vasile Costel SisermanVSVasile Costel Siserman
- Elena Mihaela JianuEJElena Mihaela Jianu
- Tudor DruganTudor Drugan
- Sorana D. BolboacăSorana D. Bolboacă
Open Access
- 27 April 2024
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 14 (9) , 914
Abstract
The primary targets of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the lungs are type I pneumocytes, macrophages, and endothelial cells. We aimed to identify lung cells targeted by SARS-CoV-2 using viral nucleocapsid protein staining and morphometric features on patients with fatal COVID-19. We conducted a retrospective analysis of fifty-one autopsy cases of individuals who tested positive for SARS-CoV-2. Demographic and clinical information were collected from forensic reports, and lung tissue was examined for microscopic lesions and the presence of specific cell types. Half of the evaluated cohort were older than 71 years, and the majority were male (74.5%). In total, 24 patients presented diffuse alveolar damage (DAD), and 50.9% had comorbidities (56.9% obesity, 33.3% hypertension, 15.7% diabetes mellitus). Immunohistochemical analysis showed a similar pattern of infected macrophages, infected type I pneumocytes, and endothelial cells, regardless of the presence of DAD (p > 0.5). The immunohistochemical reactivity score (IRS) was predominantly moderate but without significant differences between patients with and without DAD (p = 0.633 IRS for type I pneumocytes, p = 0.773 IRS for macrophage, and p = 0.737 for IRS endothelium). The nucleus/cytoplasm ratio shows lower values in patients with DAD (median: 0.29 vs. 0.35), but the difference only reaches a tendency for statistical significance (p = 0.083). Our study confirms the presence of infected macrophages, type I pneumocytes, and endothelial cells with a similar pattern in patients with and without diffuse alveolar damage.Keywords
Funding Information
- Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca (PCD 881/43)
This publication has 49 references indexed in Scilit:
- Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsiesGeroScience, 2022
- Immunohistochemical Detection of SARS-CoV-2 Antigens by Single and Multiple Immunohistochemistry2022
- Pulmonary macrophages and SARS-Cov2 infection2022
- Endothelial Dysfunction in Covid-19 InfectionThe American Journal of the Medical Sciences, 2022
- SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosisCell, 2021
- Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-αForensic Science, Medicine and Pathology, 2021
- ACE2: The Major Cell Entry Receptor for SARS-CoV-2Lung, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Alveolar epithelial cells: Master regulators of lung homeostasisThe International Journal of Biochemistry & Cell Biology, 2013
- The alveolar surface network: A new anatomy and its physiological significanceThe Anatomical Record, 1998